Yes I did Guti. DRR data from Oncosec could be a very nice surprise. I noticed on the conference call today Punit mentioned the additional data to be released at SITC. I am looking forward to the detailed charts for individual patients compared to the previous data update on the current combo study. The Merck/Bristol battle for dominance is only going to heat up and I think overall Keytruda is going to win. Oncosec has been a real underdog these past years so maybe the PISCES data will change all that.
News 
Market Data 
Discover 
AI
